Structure-activity relationships for the hypertensinogenic activity of ouabain: Role of the sugar and lactone ring

Paolo Manunta, Bruce P. Hamilton, John M. Hamlyn

Research output: Contribution to journalArticle

Abstract

Elevated levels of an endogenous ouabain circulate in many patients with essential hypertension. However, in contrast to ouabain, digoxin does not induce hypertension. This study investigated the hypothesis that within a single cardiac glycoside, the structural elements that induce hypertension differ from those responsible for high potency as a sodium pump inhibitor. Normal male Sprague-Dawley rats received infusions of vehicle (VEH), rhamnose (RHA), ouabain (OUA), ouabagenin (OGN), dihydro-ouabain (DHO), iso-ouabain (ISO), and a lactone ring opened analog (ORO) at 30 μg · kg-1 · 24 h-1 for 5 weeks via subcutaneous osmotic pumps. Cuff pressures were taken weekly. At the end of the study, trunk blood was harvested, extracted by C18 column, and subjected to high-performance liquid chromatography. Fractions were analyzed for OUA, OGN, and DHO by immunoassay. In OUA-, OGN-, and DHO-infused rats, 1 main peak of immunoreactivity corresponding to the infused agent was found. No evidence of in vivo conversion to OUA or DHO was found for any analog except ORO. At 5 weeks, systolic blood pressures in VEH, RHA, OUA, OGN, DHO, ISO, and ORO were 132±2.5, 133±1.5. 159±2.6,* 154±4,* 167±4,*† 171±2.2*† and 169±2.4*† mm Hg, respectively (*P

Original languageEnglish
Pages (from-to)472-477
Number of pages6
JournalHypertension
Volume37
Issue number2 II
Publication statusPublished - 2001

Fingerprint

Lactones
Ouabain
Structure-Activity Relationship
Rhamnose
Blood Pressure
Hypertension
Sodium-Potassium-Exchanging ATPase
Cardiac Glycosides
Digoxin
Immunoassay
Sprague Dawley Rats
High Pressure Liquid Chromatography

Keywords

  • Analogs and derivatives
  • Blood pressure
  • Glycosides
  • Sodium pump

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Structure-activity relationships for the hypertensinogenic activity of ouabain : Role of the sugar and lactone ring. / Manunta, Paolo; Hamilton, Bruce P.; Hamlyn, John M.

In: Hypertension, Vol. 37, No. 2 II, 2001, p. 472-477.

Research output: Contribution to journalArticle

@article{2468cd636b114c0b8b52351b52722817,
title = "Structure-activity relationships for the hypertensinogenic activity of ouabain: Role of the sugar and lactone ring",
abstract = "Elevated levels of an endogenous ouabain circulate in many patients with essential hypertension. However, in contrast to ouabain, digoxin does not induce hypertension. This study investigated the hypothesis that within a single cardiac glycoside, the structural elements that induce hypertension differ from those responsible for high potency as a sodium pump inhibitor. Normal male Sprague-Dawley rats received infusions of vehicle (VEH), rhamnose (RHA), ouabain (OUA), ouabagenin (OGN), dihydro-ouabain (DHO), iso-ouabain (ISO), and a lactone ring opened analog (ORO) at 30 μg · kg-1 · 24 h-1 for 5 weeks via subcutaneous osmotic pumps. Cuff pressures were taken weekly. At the end of the study, trunk blood was harvested, extracted by C18 column, and subjected to high-performance liquid chromatography. Fractions were analyzed for OUA, OGN, and DHO by immunoassay. In OUA-, OGN-, and DHO-infused rats, 1 main peak of immunoreactivity corresponding to the infused agent was found. No evidence of in vivo conversion to OUA or DHO was found for any analog except ORO. At 5 weeks, systolic blood pressures in VEH, RHA, OUA, OGN, DHO, ISO, and ORO were 132±2.5, 133±1.5. 159±2.6,* 154±4,* 167±4,*† 171±2.2*† and 169±2.4*† mm Hg, respectively (*P",
keywords = "Analogs and derivatives, Blood pressure, Glycosides, Sodium pump",
author = "Paolo Manunta and Hamilton, {Bruce P.} and Hamlyn, {John M.}",
year = "2001",
language = "English",
volume = "37",
pages = "472--477",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2 II",

}

TY - JOUR

T1 - Structure-activity relationships for the hypertensinogenic activity of ouabain

T2 - Role of the sugar and lactone ring

AU - Manunta, Paolo

AU - Hamilton, Bruce P.

AU - Hamlyn, John M.

PY - 2001

Y1 - 2001

N2 - Elevated levels of an endogenous ouabain circulate in many patients with essential hypertension. However, in contrast to ouabain, digoxin does not induce hypertension. This study investigated the hypothesis that within a single cardiac glycoside, the structural elements that induce hypertension differ from those responsible for high potency as a sodium pump inhibitor. Normal male Sprague-Dawley rats received infusions of vehicle (VEH), rhamnose (RHA), ouabain (OUA), ouabagenin (OGN), dihydro-ouabain (DHO), iso-ouabain (ISO), and a lactone ring opened analog (ORO) at 30 μg · kg-1 · 24 h-1 for 5 weeks via subcutaneous osmotic pumps. Cuff pressures were taken weekly. At the end of the study, trunk blood was harvested, extracted by C18 column, and subjected to high-performance liquid chromatography. Fractions were analyzed for OUA, OGN, and DHO by immunoassay. In OUA-, OGN-, and DHO-infused rats, 1 main peak of immunoreactivity corresponding to the infused agent was found. No evidence of in vivo conversion to OUA or DHO was found for any analog except ORO. At 5 weeks, systolic blood pressures in VEH, RHA, OUA, OGN, DHO, ISO, and ORO were 132±2.5, 133±1.5. 159±2.6,* 154±4,* 167±4,*† 171±2.2*† and 169±2.4*† mm Hg, respectively (*P

AB - Elevated levels of an endogenous ouabain circulate in many patients with essential hypertension. However, in contrast to ouabain, digoxin does not induce hypertension. This study investigated the hypothesis that within a single cardiac glycoside, the structural elements that induce hypertension differ from those responsible for high potency as a sodium pump inhibitor. Normal male Sprague-Dawley rats received infusions of vehicle (VEH), rhamnose (RHA), ouabain (OUA), ouabagenin (OGN), dihydro-ouabain (DHO), iso-ouabain (ISO), and a lactone ring opened analog (ORO) at 30 μg · kg-1 · 24 h-1 for 5 weeks via subcutaneous osmotic pumps. Cuff pressures were taken weekly. At the end of the study, trunk blood was harvested, extracted by C18 column, and subjected to high-performance liquid chromatography. Fractions were analyzed for OUA, OGN, and DHO by immunoassay. In OUA-, OGN-, and DHO-infused rats, 1 main peak of immunoreactivity corresponding to the infused agent was found. No evidence of in vivo conversion to OUA or DHO was found for any analog except ORO. At 5 weeks, systolic blood pressures in VEH, RHA, OUA, OGN, DHO, ISO, and ORO were 132±2.5, 133±1.5. 159±2.6,* 154±4,* 167±4,*† 171±2.2*† and 169±2.4*† mm Hg, respectively (*P

KW - Analogs and derivatives

KW - Blood pressure

KW - Glycosides

KW - Sodium pump

UR - http://www.scopus.com/inward/record.url?scp=0035090156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035090156&partnerID=8YFLogxK

M3 - Article

C2 - 11230321

AN - SCOPUS:0035090156

VL - 37

SP - 472

EP - 477

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2 II

ER -